UCLE US NUCLEAR CORP

US Nuclear Signs Agreement With China National Nuclear Corporation’s Subsidiary

US Nuclear Signs Agreement With China National Nuclear Corporation’s Subsidiary

Los Angeles, CA, Jan. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (OTC: UCLE) has signed a “Cooperation Agreement” with Dalian Zhonghe Scientific and Technological Development Co., a subsidiary of China National Nuclear Corporation (CNNC), to design, build, and mass produce radiation detectors and systems for the growing China nuclear market. 

China is the world’s major builder of nuclear power plants, with 46 in operation, 15 under construction, and around 200 planned.  Each nuclear power plant requires about $8 million worth of radiation detection equipment.  Currently, around 80% of that radiation detection equipment is imported into China at a steep cost.  Importing is not favorable due to the high cost and because functionality has been customized for the country of origin and does not always fit local procedures, regulations, and language.  US Nuclear aims to solve this problem. 

Under this new cooperation agreement, US Nuclear will work with Dalian Zhonghe to design the perfect radiation detection systems for use in Chinese Nuclear Power Plants.  These systems are planned to be built at a factory in China to be cost-competitive.  Furthermore, this factory will be a new trading partner for US Nuclear, buying sub-assemblies and helping with any required exports to China. 

CNNC is the most important player in China’s applied nuclear technology field and is also the earliest company that can design, engineer, and manufacture such products.  Furthermore, CNNC is affiliated with China Isotope and Radiation Corporation (CIRC), the biggest nuclear medicine manufacturer in China.  The CIRC can be an excellent customer for US Nuclear and MIFTEC’s medical isotope generator business. 

Safe Harbor Act

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at , or the company’s website at

CONTACT:

US Nuclear Corp. (OTCBB: UCLE)

Robert I. Goldstein, President, CEO, and Chairman

Rachel Boulds, Chief Financial Officer

(818) 883 7043

Email:

EN
21/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on US NUCLEAR CORP

 PRESS RELEASE

 US Nuclear Announces 3rd Quarter Financials and Launch of New Marketi...

 US Nuclear Announces 3rd Quarter Financials and Launch of New Marketing Initiatives LOS ANGELES, Dec. 04, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce that the 3rd quarter 2024 loss was reduced to $110,971 from $760,062 in 2023, a reduction of 89%. For the nine-month period, losses were reduced from $2,296,114 in 2023, to $728,320 in 2024, a reduction of $1,567,794, or 68%. “These improvements in our path to profitability are just the beginning,” said Bob Goldstein, CEO of US Nuclear. “We’re working towards reducing our operating expenses 20%, while growi...

 PRESS RELEASE

US Nuclear Announces a Significant Improvement in 3rd Quarter Financia...

US Nuclear Announces a Significant Improvement in 3rd Quarter Financials LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC: UCLE) is pleased to announce they have made significant progress in reducing current liabilities by over $3 million in the 3rd quarter, while projecting a swing in profitability of over $1 million from the 3rd quarter of 2023. Results will be released with the 3rd quarter results later this month. In conjunction with these efforts, the Company has increased pricing by 5.5% effective this month, and has begun a cost reduction program to reduce expe...

 PRESS RELEASE

US Nuclear Forced to Expand Its Ohio Production Floor and Shipment Vol...

US Nuclear Forced to Expand Its Ohio Production Floor and Shipment Volume to Keep Up With the Surge of Incoming Orders LOS ANGELES, CA, Aug. 19, 2024 (GLOBE NEWSWIRE) -- To help keep up with surging incoming purchase orders, US Nuclear Corp. (OTC: UCLE) is now significantly expanding their Overhoff (Ohio) production floor area to increase shipment volume. This is necessary due to increasingly high demand for their famous tritium monitors. This is all caused by the AI nuclear energy boom and the big money, worldwide scramble to design and build the long awaited fusion energy generators th...

 PRESS RELEASE

S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power ...

S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power Grid LOS ANGELES, CA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Worldwide Energy Shortages and Soaring Prices are Driving Nuclear Power Growth for US Nuclear Corp. (OTC-QB: UCLE). Extreme weather, soaring energy prices, and outdated energy infrastructure are leaving millions of people at risk of losing power, and the problems continue to get worse. The U.S. and countries around the world are increasingly turning to nuclear power in an effort to keep up with the surging demand, with the U.S. alone aiming to triple nuclear capac...

 PRESS RELEASE

US Nuclear Corp. Announces First Quarter 2024 Results

US Nuclear Corp. Announces First Quarter 2024 Results LOS ANGELES, CA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- US Nuclear Corp. (OTC-QB: UCLE), a leading manufacturer of advanced radiation, chemical, and biological detection and UAV instrumentation, recently announced the financial results for the first quarter ended March 31, 2024. Sales for the three months ended March 31, 2024 were $627,750Gross profit was $353,769Gross margins were 56.36% as compared to 67.25% for the same period last yearSelling, general, and administrative expense were $498,198 compared to $735,825 for ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch